Mode
Text Size
Log in / Sign up
N/A N=10,252 Randomized Prevention

IMPROVE AKI Cluster-Randomized Trial

Acute Kidney Injury

Enrolled (actual)
10,252
Serious AEs
25.1%
Results posted
Mar 2025
Primary outcome: Primary: Acute Kidney Injury — 110; 190; 122; 88 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
AKI Prevention Toolkit (Behavioral); Technical Assistance (TA) (Behavioral); Virtual Learning Collaborative (VLC) (Behavioral); Automated Surveillance Reporting (ASR) (Behavioral)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Dartmouth-Hitchcock Medical Center
Primary completion
Nov 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Acute Kidney Injury
110; 190; 122; 88

Summary

When a person has an imaging procedure that uses radio-contrast dye, there is a possibility of damage to that person's kidneys, which could result in being on dialysis or early death. The investigators are testing novel coaching and automated tools to help healthcare teams apply approaches that have been shown to prevent damage to kidneys during a cardiac catheterization procedure. The results of our study will help inform health care leaders on how to implement low-cost preventive strategies through team-based coaching and surveillance reporting for kidney injury and other patient safety priorities to every hospital in the United States.

Eligibility Criteria

Inclusion Criteria

  • VA Site Inclusion Criteria: All VA medical centers with a cardiac catheterization laboratory are eligible, and all catheterization operators at a site are included.
  • Patient Inclusion Criteria: Among these sites, only patients aged 18 or greater with pre-existing CKD who undergo diagnostic coronary angiography or percutaneous coronary intervention (PCI or angioplasty) will be enrolled in the trial. CKD will be determined by a pre-existing CKD diagnosis in the VA medical record, or by two or more estimated glomerular filtration rates <60 (ml/min/1.73 m2) at least 90-days apart prior to presentation.

Exclusion Criteria

  • Patient Exclusion Criteria: Patients with a history of dialysis (hemodialysis, peritoneal dialysis), under the age of 18, or no evidence of pre-existing CKD will be excluded. Cardiac catheterization (also referred to as coronary angiography) is defined as a procedure in which a catheter is inserted into the femoral or radial artery and is threaded to the cardiac vasculature where radio-contrast dye is administered and a series of x-rays obtained in order to visualize the coronary arterial anatomy. PCI is when a clinical intervention is then performed to address any treatable pathology that is found.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03556293). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search